欧盟HMA药品数据库(European Union HMA Authorisation of Medicines DataBase)
MR编号UK/H/6922/004
药品名称Levothyroxine 100 mcg tablets
活性成分
    • Levothyroxine sodium 100.0 mg
剂型Tablet
上市许可持有人Abdi Farma Unipessoal Lda. Edificio D.pedro Rua De Malhões Paço De Arcos Lisboa 2770-071 Portugal
参考成员国 - 产品名称United Kingdom (UK)
PL39360/0019
互认成员国 - 产品名称
    • Ireland (IE)
许可日期2019/01/28
最近更新日期2019/01/28
药物ATC编码
    • H03AA01 levothyroxine sodium
申请类型
  • TypeLevel1:Abridged
  • TypeLevel2:Initial Application
  • TypeLevel3:Generic
  • TypeLevel4:Chemical Substance
  • TypeLevel5:Prescription Only
附件文件下载
    市场状态Withdrawn(注:已撤市)
    撤市原因:1.The company decided to withdraw the application. At the time of withdrawal, the MS considered that the data provided did not allow to conclude on a positive benefit-risk balance as major objections were raised.
    ©2006-2025 Drugfuture->European Union HMA Authorisation of Medicines DataBase